1. Home
  2. FORM vs ALKS Comparison

FORM vs ALKS Comparison

Compare FORM & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FormFactor Inc. FormFactor Inc.

FORM

FormFactor Inc. FormFactor Inc.

N/A

Current Price

$114.16

Market Cap

9.0B

Sector

Technology

ML Signal

N/A

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$48.33

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FORM
ALKS
Founded
1993
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
8.7B
IPO Year
2002
2012

Fundamental Metrics

Financial Performance
Metric
FORM
ALKS
Price
$114.16
$48.33
Analyst Decision
Buy
Buy
Analyst Count
9
14
Target Price
$98.25
$43.43
AVG Volume (30 Days)
1.3M
1.6M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.96
N/A
Revenue
N/A
$1,475,899,000.00
Revenue This Year
$19.43
$24.26
Revenue Next Year
$7.31
$4.47
P/E Ratio
$120.53
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.81
$25.17
52 Week High
$160.27
$55.67

Technical Indicators

Market Signals
Indicator
FORM
ALKS
Relative Strength Index (RSI) 47.85 44.95
Support Level $113.14 $47.66
Resistance Level $158.56 $51.25
Average True Range (ATR) 7.60 1.55
MACD 0.23 -0.16
Stochastic Oscillator 18.16 29.21

Price Performance

Historical Comparison
FORM
ALKS

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: